Clinical Trial 40200

share

Garden Grove, CA 92845


Study Summary:

A phase II randomised, double-blind, placebo-controlled study to
evaluate the efficacy, safety, and tolerability of orally administered BI
409306 during a 28-week treatment period as adjunctive therapy to
antipsychotic treatment for the prevention of relapse in patients with
schizophrenia.


Qualified Participants Must:

• Male or female patients
• ICD-10 diagnosis of schizophrenia older than one year prior to randomisation


Qualified Participants May Receive:

Compensation for time and travel


Research Site Profile

View Clinic Profile


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you would like to get the phone number or be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.